|Articles|November 22, 2022
Liposomal and Nanoparticle Technology at Pfizer Melbourne
Author(s)Pfizer CentreOne
Liposomal drug delivery systems have become an important part of biologics developers’ armories, with several marketed products now available
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
